Taking tamoxifen (Novaldex) for 10 years after primary treatment leads to a greater reduction in breast cancer recurrences and deaths than taking the drug for only 5 years according to findings from the ATLAS trial, which were presented at the San Antonio Breast Cancer Symposium.
Nearly 7,000 women with early-stage, estrogen-receptor positive breast cancer were enrolled in the trial between 1996 and 2005. After taking tamoxifen for 5 years, participants were randomly assigned to continue taking tamoxifen for another 5 years or to stop taking it. Among the women who took tamoxifen for 10 years, the risk of breast cancer returning between 10 and 14 years after starting tamoxifen was 25 percent lower than it was among women who took it for 5 years, and the risk of dying from breast cancer was nearly 30 percent lower. Interestingly, the positive difference in outcome only emerged after the 10-year mark of taking the drug, and not between 5 -9+ years.
Tamoxifen can have side effects, including hot flashes, fatigue, and an increased risk of blood clots and endometrial cancer but there was no rise in the occurrence of these side effects for the women who took the drug for the extended period. Women with a higher risk of their cancer returning long after adjuvant therapy ends, such as those whose cancers had infiltrated their lymph nodes or who had larger tumors, "will definitely be strong candidates for continuation of [tamoxifen] therapy," Dr Ravdin of the University of Texas Health Sciences Center at San Antonio, who moderated the press briefing said. But a woman at low risk of recurrence at any point "may very well rationally decide she doesn't want to take tamoxifen beyond 5 years”.
Both Pre-menopausal and Post-menopausal women could be candidates for this extended use of tamoxifen adjuvant therapy. It is important to consult with your doctor about the efficacy of this treatment for you.
~Cameron Phillips
NCI Cancer Bulletin December 12, 2012 vol 9 number 24

The American Association of University Women (AAUW) recently published a report indicating that the pay gap, or the earning difference between men and women, is still an issue today, and often manifests in the very first paycheck a female college graduate receives. The
A recent study published in the Obstetrics and Gynecology edition of the online journal
Many African-American women in a small survey said they avoided exercise at least sometimes because it could ruin their hairstyles, researchers reported.
On Tuesday, December 18th the
Using a mobile app that tracks eating and activity helped people lose an average of 15 pounds and keep it off for at least a year, according to a new Northwestern Medicine study. But the technology only aided weight loss when its users also attended regular classes about nutrition and exercise. The app alone didn’t help.
When female childhood cancer survivors grow up, are they more likely to experience an earlier onset of menopause? If so, what are the risk factors associated with early menopause? These were the questions asked by researchers at the French public hospital organization (AP-HP), the Institute Gustave Roussy, and the Universite Paris-Sud. Their study, published in the November 12th edition of
'Tis the season for reindeer watching as children listen for Santa and his sleigh bells, but beware! A study from Sweden reports that reindeer may be carrying the larvae of a bumble-like fly called Hypoderma tarandi. Its eggs laid in the hair of reindeer hatch into larvae that penetrate the skin like a needle. The larvae mature into flies that burst out of the skin and begin the cycle all over again---and can even lay their eggs in humans!